Article
Respiratory virus disease and outcomes at a large academic medical center in the United States: a retrospective observational study of the early 2023/2024 respiratory viral season.
Microbiology spectrum - 3 Oct 2024
Mostafa Heba H, Fall Amary, Norton Julie M, Sachithanandham Jaiprasath, Yunker Madeline, Abdullah Omar, Hanlon Ann, Gluck Linda, Morris C Paul, Pekosz Andrew, Klein Eili Y
Abstract excerpt
Respiratory disease, attributed to influenza, respiratory syncytial virus (RSV), and SARS-CoV-2, was reported nationally during the 2023/2024 respiratory viral season. The emergence of novel SARS-CoV-2 variants was considered a significant factor contributing to the rise in COVID-19 cases. Data from the Johns Hopkins Hospital System (JHHS) showed that enterovirus/rhinovirus had also been circulating at high...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.